Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients

  1. Bandres, E.
  2. Rodriguez, J.
  3. Hernandez, A.
  4. Bitarte, N.
  5. Ramirez, N.
  6. Diaz-Gonzalez, J. A.
  7. Chopitea, A.
  8. Ponz, M.
  9. Zarate, R. N.
  10. Garcia-Foncillas, J.
Journal:
EJC SUPPLEMENTS

ISSN: 1359-6349

Year of publication: 2009

Volume: 7

Issue: 2

Pages: 113-113

Congress: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology

Type: Conference paper

DOI: 10.1016/S1359-6349(09)70388-X GOOGLE SCHOLAR
Data source: WoS